The Purdue and USDA research team developed a method to test toxins from other plants on Hessian fly larvae. The test simulates the effect of a transgenic plant without the lengthy and costly procedures necessary to actually create those plants.
"For years, people have tried to develop a bioassay, but that hadn't happened until now," said Richard Shukle, a research scientist with the USDA Agricultural Research Service Crop Production and Pest Control Research Unit working in Purdue Entomology, whose findings were published in the Journal of Insect Physiology.
Shukle said the 33 genes known to give wheat resistance to Hessian fly attacks have been failing, causing scientists to develop methods to stack those genes together as a defense. But another solution could include adding other plants' toxins to wheat to bolster its defenses.
The problem has been with the unique way in which Hessian fly larvae attack and feed off wheat. The larvae secrete a substance onto the plants that creates a sort of wound on the plant tissue, opening it up for the larvae to feed on.
Toxins can be tested on other pests by adding those toxins to a plant-based artificial diet and feeding them to the insects. But Hessian fly larvae won't take the bait, meaning that until now the only way to test poisons from other plants was to create lines of transgenic wheat and feed them to the flies.
"This feeding assay is significant. This gives us a way to test these toxins," said Christie Williams, a co-author of the findings and a research scientist with the USDA Agricultural Research Service Crop Production and Pest Control Research Unit working in Purdue Entomology. "A preliminary chemical assay might give us promising results. But then you could go to all the trouble of making a transgenic plant based on that chemical test and have it not work."
To get the toxins into the fly larvae, the scientists allowed Hessian flies to lay eggs on the leaves of seedling wheat plants. When the eggs hatched, the plants were taken from the soil, their roots cleaned and trimmed, and then replanted as hydroponics with the toxic proteins added to the plants' water.
"The plant is just acting like a big straw taking up the toxins," Williams said. "It's just like putting a carnation into a cup of colored water and watching the flower change colors."
When the fly larvae attacked and fed as usual, they were also ingesting the toxins that were taken up through the water.
"We knew they would feed on the plant," said Subhashree Subramanyam, a Purdue agronomy research associate. "So we used the plant as the translocation medium."
Protein immunoblot detection tests, which use antibodies to detect the presence of a particular protein, showed that the larvae had ingested the toxins added to the water.
The team tested nine lectins ¨l antinutrient proteins that disrupt digestive function. In particular, Hessian fly larvae responded to snowdrop lectin, which comes from snowdrop bulbs, a flowering plant.
Larvae that ingested the snowdrop lectin developed only half as fast as the control larvae. There was also evidence of disruption of the microvilli ¨l fingerlike extensions in the midgut that aid in nutrient uptake.
"It is possible that snowdrop lectin, by itself, could give wheat better resistance to the Hessian fly," Shukle said.
The scientists plan to have a transgenic version of the wheat developed for further testing. The USDA funded their work.
A publication-quality photo is available at http://news.uns.purdue.edu/images/2011/shukle-hessianlarvae.jpg
Abstract for the research in this release is available at: http://www.purdue.edu/newsroom/research/2011/111212ShukleTransgenic.html
Brian Wallheimer | EurekAlert!
Biophysicists reveal how optogenetic tool works
29.05.2020 | Moscow Institute of Physics and Technology
Mapping immune cells in brain tumors
29.05.2020 | University of Zurich
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering